Articles by tag: gennaya-terapiya

Gene therapy for deafness otarmeni EMA: accelerated review 2026

EMA accepted the application for gene therapy otarmeni for the treatment of hereditary deafness OTOF. Market analysis, forecasts, price and implications for the industry. Read.

Gene therapy without registration: Russia legalizes bespoke drugs

Russia will allow individual gene therapy for orphan diseases without state registration. A chance for children with deadly mutations. Learn how it works.

Fidanacogene elaparvovec: EMA approves gene therapy for hemophilia B

Analysis of Pfizer's first gene therapy for hemophilia B: 96% reduction in bleeding, competition with Hemgenix, and hidden risks for the market. Learn the details.